Drug intelligence / Profile preview

Acetal-SP

Development stage
Unknown
Lead developer
Zytras Life Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

Acetal-SP is a fixed-dose combination oral tablet manufactured and marketed by Zytras Life Sciences, primarily in the Indian market. It contains three active ingredients: aceclofenac (100 mg), paracetamol (500 mg), and serratiopeptidase (15 mg). Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation by inhibiting cyclooxygenase enzymes. Paracetamol (acetaminophen) serves as an analgesic and antipyretic, providing additional pain relief and fever reduction. Serratiopeptidase is a proteolytic enzyme that helps reduce swelling and edema by breaking down abnormal proteins and inflammatory mediators at the site of injury. This combination is indicated for the relief of pain and inflammation associated with musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, sports injuries, and post-operative recovery.

Brand names
Acetal-SP
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Acetal-SP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetal-SP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call